Certification_Amylum (Hangzhou) Biomedical Co., Ltd

Company Profile

Amylum (Hangzhou) Biomedical Co., Ltd was established on July 20, 2023, with its registered address located on the first and second floors of Workshop 1, No. 300 Xiafen Road, Taozhuang Town, Jiashan County, Jiaxing City, Zhejiang Province. Its business scope includes licensed projects such as drug production (projects that require approval by law can only be carried out after approval by relevant departments, and specific business projects are subject to the approval results). General project: Manufacturing of medical packaging materials; Sales of packaging materials and products.

Our Culture

Corporate positioning

Pioneering Industrial Technology, Deepening Expertise in Materials and Applications.

Business purpose

Respecting Originality, Objective Principles, and Our Customers.

Corporate spirit

Embracing Boldness, Connectivity, and Sharing.

Corporate Beliefs

Grounded in the Substitution of Traditional Leather and Plastics with Innovative Materials, and Leve

Corporate mission

Inheriting the Legacy of Traditional Manufacturing, Pioneering the Future of Advanced Manufacturing.

Corporate Vision

Building a Synergistic Supply Chain, Platform, and Ecosystem.

Development

in the future...

2023

July 20, 2023 Amilun (Jiaxing) Biopharmaceutical Co., Ltd. was officially established.

August 2023 Relocated to Feixu Technology Park, Taozhuang Town, Jiashan County.

September 2023 Commenced construction of the Class 100,000 cleanroom facility.

September – December 2023 Completed workshop construction and the installation of water, electricity, and gas utilities.

2024

January 2024 Installed and commissioned the AGV system and software; filed applications for corresponding patents and software copyrights.

February 2024 Obtained the third-party cleanroom validation report.

March 2024 Conducted production testing with raw materials.

March 2024 Achieved trial production of gelatin capsules, HPMC empty capsules, and hydroxypropyl starch empty capsules.

April 2024 Submitted products to the Hangzhou Institute for Drug Control and the Zhejiang Institute for Drug Control for specialized testing.

May 2024 Initiated cooperation discussions on starch-based soft capsules with Chunjia Health (Guangzhou) Co., Ltd.

August 2024 Participated in the preparatory work for the establishment of Amilun (Tongchuan) Biotechnology Co., Ltd.

2025

January 2025 Initiated discussions on the joint development of biodegradable films with Shaanxi Zhongyu New Materials Co., Ltd.

June 2025 Initiated relocation to Qingshanhu Industrial Park.

July 2025 Initiated corporate registration changes.

August 2025 Officially renamed Amilun (Hangzhou) Biopharmaceutical Co., Ltd.

October 2025 Commenced the design of the new factory and production workshops.

December 2025 Launched various renovation and fit-out projects for the new facility.